Fred Alger Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $655K | Sell |
3,795
-61,011
| -94% | -$10.5M | ﹤0.01% | 377 |
|
|
2025
Q1 | $10.1M | Sell |
64,806
-47,048
| -42% | -$7.33M | 0.06% | 171 |
|
|
2024
Q4 | $15.4M | Sell |
111,854
-146,356
| -57% | -$20.1M | 0.07% | 154 |
|
|
2024
Q3 | $38.6M | Sell |
258,210
-48,863
| -16% | -$7.3M | 0.19% | 89 |
|
|
2024
Q2 | $41.9M | Buy |
307,073
+120,952
| +65% | +$16.5M | 0.2% | 84 |
|
|
2024
Q1 | $28.1M | Sell |
186,121
-7,381
| -4% | -$1.12M | 0.14% | 120 |
|
|
2023
Q4 | $24.4M | Sell |
193,502
-76,503
| -28% | -$9.64M | 0.13% | 131 |
|
|
2023
Q3 | $25.3M | Sell |
270,005
-81,006
| -23% | -$7.59M | 0.15% | 132 |
|
|
2023
Q2 | $31.3M | Buy |
+351,011
| New | +$31.3M | 0.16% | 134 |
|
|
2023
Q1 | – | Sell |
-14,556
| Closed | -$1.78M | – | 524 |
|
|
2022
Q4 | $1.78M | Buy |
+14,556
| New | +$1.78M | 0.01% | 352 |
|
|
2020
Q3 | – | Sell |
-5,000
| Closed | -$740K | – | 466 |
|
|
2020
Q2 | $740K | Hold |
5,000
| – | – | ﹤0.01% | 372 |
|
|
2020
Q1 | $563K | Sell |
5,000
-500
| -9% | -$56.3K | ﹤0.01% | 352 |
|
|
2019
Q4 | $765K | Sell |
5,500
-1,500
| -21% | -$209K | ﹤0.01% | 362 |
|
|
2019
Q3 | $674K | Hold |
7,000
| – | – | ﹤0.01% | 360 |
|
|
2019
Q2 | $806K | Sell |
7,000
-1,500
| -18% | -$173K | ﹤0.01% | 353 |
|
|
2019
Q1 | $1M | Buy |
+8,500
| New | +$1M | ﹤0.01% | 333 |
|